Market Access News | pharmaphorum

News

AbbVie launches pump-based Parkinson’s drug in EU

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion ther

News

FDA blocks Astellas’ Claudin cancer drug over manufacturing

Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted drug can

News

China is third country to approve Alzheimer’s drug Leqembi

Eisai and Biogen have a third regulatory approval for their amyloid-targeting Alzheimer’s disease therapy Leqembi, after it was greenlit by China’s National Medical Produc

News

Florida is first US state cleared to import Canadian drugs

The FDA has approved the first request from a US state to import prescription medicines from Canada, giving the green light to Florida for a programme that aims to reduce

News

Lilly launches telehealth option for obesity and other drugs

Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that could shake up

News

MHRA’s post-Brexit mutual recognition framework goes live

The UK medicines regulator has launched its mutual recognition framework for authorising medicines in a move that it says will help to bring new drugs to patients in the U

AbbVie launches pump-based Parkinson’s drug in EU

FDA blocks Astellas’ Claudin cancer drug over manufacturing

China is third country to approve Alzheimer’s drug Leqembi

Florida is first US state cleared to import Canadian drugs

Lilly launches telehealth option for obesity and other drugs

MHRA’s post-Brexit mutual recognition framework goes live

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks